Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Starting soon

Conditions studied: Neuroendocrine Tumors

In brief

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This research will admit a wide range of data on the clinical study experience of neuroendocrine tumor patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with neuroendocrine tumor.

Key facts

Study ID

NCT05967481

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-08-01

Expected to finish

2026-08-01

Last updated by the study team

2023-08-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is at least 18 years of age
• Diagnosis of neuroendocrine tumor
• Ability to understand and the willingness to sign a written informed consent document

You may not qualify if…

• Enrolled in another research study
• Patients with psychiatric illness/social situations that would limit compliance with study requirements
• Pregnant or lactating woman

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.